BIO-RAD LABORATORIES, INC. BIO
출처: SEC EDGAR XBRL companyconcept (10-K) · 통화 USD
검증 ✓ 매출·재무 = SEC EDGAR XBRL companyconcept (10-K) 공시원본 (AI 추정 0) ✓ 재무 신호 = 공시 숫자 계산 (AI 아님)
$789M$1.6B$2.4B$3.2B $2.9B 20082025
🏭 사업부 흥망 해부도(성장·고전·철수·실패) 펼쳐보기 →
재무 신호 · 공시 숫자 계산 · AI 아님 · 판정 없음
✦ 흥망사
버튼을 누르면 위 공시 숫자에 근거한 흥망사를 생성합니다 — AI 서술, 예측·투자조언 없음.
▾ 데이터 표 보기
연도 매출영업이익순이익자산부채 FCF 영업이익률 매출 YoY
2008 $1.8B$183M$90M 10.4%
2009 $1.8B$231M$145M$2.5B$1.3B $257M 12.9% ▲ 1.1%
2010 $1.9B$284M$185M$3.1B$1.5B $137M 14.7% ▲ 8.0%
2011 $2.1B$305M$179M$3.1B$1.4B $160M 14.7% ▲ 7.6%
2012 $2.1B$264M$165M$3.4B$1.4B $124M 12.8% ▼ 0.2%
2013 $2.1B$169M$78M$3.4B$1.2B $62M 7.9% ▲ 3.1%
2014 $2.2B$150M$89M$3.3B$1.2B $152M 6.9% ▲ 2.0%
2015 $2B$167M$109M$3.7B$1.2B $74M 8.3% ▼ 7.2%
2016 $2.1B$56M$26M$3.9B$1.3B $75M 2.7% ▲ 2.4%
2017 $2.2B$119M$122M$4.3B$1.3B -$7M 5.5% ▲ 4.4%
2018 $2.3B-$103M$366M$5.6B$1.6B $156M -4.5% ▲ 6.0%
2019 $2.3B$230M$1.8B$8B$2.3B $359M 9.9% ▲ 1.0%
2020 $2.5B$421M$3.8B$13B$3.1B $476M 16.6% ▲ 10.1%
2021 $2.9B$500M$4.3B$17.8B$4.1B $536M 17.1% ▲ 14.8%
2022 $2.8B$483M-$3.6B$13.5B$3.9B $82M 17.2% ▼ 4.1%
2023 $2.7B$338M-$637M$12.3B$3.6B $218M 12.6% ▼ 4.7%
2024 $2.6B$269M-$1.8B$9.4B$2.8B $290M 10.5% ▼ 3.9%
2025 $2.6B$47M$760M$10.6B$3.1B $375M 1.8% ▲ 0.7%